Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteremia Treated with Vancomycin at an Institution with Suppressed Minimum Inhibitory Concentration (MIC) Reporting: Impact of Vancomycin MIC
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.